308 related articles for article (PubMed ID: 27109278)
1. Human papillomavirus-related oropharyngeal cancer in the HIV-infected population.
Wang CC; Palefsky JM
Oral Dis; 2016 Apr; 22 Suppl 1():98-106. PubMed ID: 27109278
[TBL] [Abstract][Full Text] [Related]
2. The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer.
Guo T; Eisele DW; Fakhry C
Cancer; 2016 Aug; 122(15):2313-23. PubMed ID: 27152637
[TBL] [Abstract][Full Text] [Related]
3. Sexual health in oral oncology: breaking the news to patients with human papillomavirus-positive oropharyngeal cancer.
Evans M; Powell NG
Head Neck; 2014 Nov; 36(11):1529-33. PubMed ID: 24913820
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus-associated cutaneous disease burden in human immunodeficiency virus (HIV)-positive patients: the role of human papillomavirus vaccination and a review of the literature.
Bacik LC; Chung C
Int J Dermatol; 2018 Jun; 57(6):627-634. PubMed ID: 29152727
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus-related malignancies in HIV infection: anal and oropharyngeal cancers.
Wilkin TJ
Top Antivir Med; 2018 Sep; 26(3):85-88. PubMed ID: 30384331
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults.
Beachler DC; Sugar EA; Margolick JB; Weber KM; Strickler HD; Wiley DJ; Cranston RD; Burk RD; Minkoff H; Reddy S; Xiao W; Guo Y; Gillison ML; D'Souza G
Am J Epidemiol; 2015 Jan; 181(1):40-53. PubMed ID: 25480823
[TBL] [Abstract][Full Text] [Related]
7. Oropharyngeal HPV infection: prevalence and sampling methods among HIV-infected men in South Africa.
Chikandiwa A; Pisa PT; Chersich MF; Muller EE; Mayaud P; Delany-Moretlwe S
Int J STD AIDS; 2018 Jul; 29(8):776-780. PubMed ID: 29471764
[TBL] [Abstract][Full Text] [Related]
8. The epidemiology of the human papillomavirus related to oropharyngeal head and neck cancer.
Gooi Z; Chan JY; Fakhry C
Laryngoscope; 2016 Apr; 126(4):894-900. PubMed ID: 26845348
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus, cancer and vaccination.
Heard I
Curr Opin HIV AIDS; 2011 Jul; 6(4):297-302. PubMed ID: 21519247
[TBL] [Abstract][Full Text] [Related]
10. Considerations in Human Papillomavirus-Associated Oropharyngeal Cancer Screening: A Review.
Day AT; Fakhry C; Tiro JA; Dahlstrom KR; Sturgis EM
JAMA Otolaryngol Head Neck Surg; 2020 Jul; 146(7):656-664. PubMed ID: 32379293
[TBL] [Abstract][Full Text] [Related]
11. Patterns and trends of HPV-related cancers other than cervix in South Africa from 1994-2013.
Chikandiwa A; Pisa PT; Sengayi M; Singh E; Delany-Moretlwe S
Cancer Epidemiol; 2019 Feb; 58():121-129. PubMed ID: 30557819
[TBL] [Abstract][Full Text] [Related]
12. HPV-Associated Oropharyngeal Cancer in the HIV/AIDS Patient.
Cameron JE; Hagensee M
Cancer Treat Res; 2019; 177():131-181. PubMed ID: 30523624
[TBL] [Abstract][Full Text] [Related]
13. [The disease burden of human papillomavirus in men is substantial and can potentially be prevented].
Kiellberg Larsen H; Kofoed K; Sand C
Ugeskr Laeger; 2013 Feb; 175(6):349-53. PubMed ID: 23402241
[TBL] [Abstract][Full Text] [Related]
14. HPV-Associated Anal Cancer in the HIV/AIDS Patient.
Wang CJ; Palefsky JM
Cancer Treat Res; 2019; 177():183-209. PubMed ID: 30523625
[TBL] [Abstract][Full Text] [Related]
15. Current Trends in the Incidence and Presentation of Oropharyngeal Cancer.
Younai FS
J Calif Dent Assoc; 2016 Feb; 44(2):93-100. PubMed ID: 26930752
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus-related diseases: oropharynx cancers and potential implications for adolescent HPV vaccination.
Gillison ML
J Adolesc Health; 2008 Oct; 43(4 Suppl):S52-60. PubMed ID: 18809146
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States--do we need a broader vaccine policy?
Osazuwa-Peters N
Vaccine; 2013 Nov; 31(47):5500-5. PubMed ID: 24095883
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults.
Beachler DC; Weber KM; Margolick JB; Strickler HD; Cranston RD; Burk RD; Wiley DJ; Minkoff H; Reddy S; Stammer EE; Gillison ML; D'Souza G
Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):122-33. PubMed ID: 22045700
[TBL] [Abstract][Full Text] [Related]
19. Could the human papillomavirus vaccination be cost-effective in males for the prevention of oropharyngeal cancer?
Isaranuwatchai W; Graham DM; Siu LL; Hoch JS
Expert Rev Pharmacoecon Outcomes Res; 2014 Dec; 14(6):763-5. PubMed ID: 25095728
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus, human immunodeficiency virus and immunosuppression.
Denny LA; Franceschi S; de Sanjosé S; Heard I; Moscicki AB; Palefsky J
Vaccine; 2012 Nov; 30 Suppl 5():F168-74. PubMed ID: 23199960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
